In this episode of the Tech Optimist podcast, Grant Demeter (Principal at AV) interviews Mike Collins about his personal experience with Mounjaro. They discuss the drug's impact on Mike's health, the broader implications for the healthcare and investment sectors, and the future potential of GLP-1 treatments.

To Learn More:

-- Alumni Ventures (AV): www.av.vc
-- AV LinkedIn: www.linkedin.com/company/alumniventures
-- AV Healthtech Fund: www.av.vc/HealthTech
-- Tech Optimist: www.techoptimist.vc

Speakers:

-- Mike Collins - Host - www.linkedin.com/in/mike-collins-362100
-- Grant Demeter - Guest - www.linkedin.com/in/grant-demeter-a90865116

Chapters:

• (00:00) - Intro

Legal Disclosure:

-- https://av-funds.com/tech-optimist-disclosures